Jpmorgan Chase & CO Sera Prognostics, Inc. Transaction History
Jpmorgan Chase & CO
- $1.23 Trillion
- Q4 2024
A detailed history of Jpmorgan Chase & CO transactions in Sera Prognostics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 775,871 shares of SERA stock, worth $3.29 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
775,871
Previous 884,867
12.32%
Holding current value
$3.29 Million
Previous $6.9 Million
2.54%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding SERA
# of Institutions
76Shares Held
20.3MCall Options Held
28.9KPut Options Held
36.8K-
Baker Bros. Advisors LP New York, NY5.43MShares$23 Million0.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.03MShares$12.9 Million0.43% of portfolio
-
Interwest Venture Management CO2.42MShares$10.2 Million21.78% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$7 Million2.79% of portfolio
-
Black Rock Inc. New York, NY1.41MShares$5.98 Million0.0% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $125M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...